Updates from The Motley Fool

Latest updates on ARADIGM CORP from Fool.com.

There is no available coverage of ARADIGM CORP at this time.

Stock Performance

ARDM vs. S&P 500 | 2 Year Performance
ARDM 1-Day Stock Chart
ARDM 5-Day Stock Chart
ARDM 1-Month Stock Chart
ARDM 3-Month Stock Chart
ARDM 6-Month Stock Chart
ARDM 1-Year Stock Chart
ARDM 2-Year Stock Chart
ARDM 5-Year Stock Chart
View Interactive ARDM Charts
Sponsored by

Key Data Points

Primary metrics and data points about ARADIGM CORP.
Current Price: $4.48
Prev Close: $4.92
Open: $4.75
Bid: $4.13
Ask: $4.95
Day's Range: $4.48 - $4.75
52wk Range: $2.60 - $7.90
Volume: 9,936
Avg Vol 14,537
Market Cap: $66.13M
P/E (ttm): -4.21
EPS (ttm): -$1.17
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ARADIGM CORP.
CAPS Rating 0 out of 5
5 Outperform
0 Underperform
CAPS All Stars
1 Outperform
0 Underperform

How do you think ARADIGM CORP will perform against the market?

You pick for ARADIGM CORP is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Igor Gonda, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ARADIGM CORP.

A pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers